Showing 2381-2390 of 19323 results for "".
Individualizing gMG Treatment: Defining Success With Each Patient
https://reachmd.com/programs/neurofrontiers/individualizing-gmg-treatment-defining-success-with-each-patient/32862/As treatment options for generalized myasthenia gravis (gMG) expand, defining success means more than just controlling symptoms—it means aligning care with each patient’s goals and lifestyle. Hear Dr. Omar Sinno, who spoke with ReachMD at the AANEM 2025 Annual Meeting in San Francisco, share insightReal-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/real-world-cdk46-inhibitor-patterns-in-hrher2-metastatic-breast-cancer/36161/CDK4/6 inhibitors play a central role in the first-line treatment of hormone receptor-positive, HER2-negative (HR+/HER2–) metastatic breast cancer, but how do they perform outside of clinical trials? That’s what a recent real-world study aimed to find out, examining treatment patterns, tolerability,Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
https://reachmd.com/programs/neurofrontiers/innovations-in-bladder-monitoring-for-ms-advancing-remote-evaluation-tools/32803/Many patients with multiple sclerosis (MS) experience neurogenic bladder symptoms—ranging from urgency and incontinence to retention and infection risk—but these issues are often underprioritized in care. Based on recent research, remote, commercially available bladder monitoring tools can help addrReviewing RSV in Immunocompromised Adults
https://reachmd.com/programs/deep-breaths-updates-chest/reviewing-rsv-in-immunocompromised-adults/15336/How common is RSV in immunocompromised adults? Dive in.The Impact of Individual Autonomic Domains in Parkinson’s Disease
https://reachmd.com/programs/neurofrontiers/the-impact-of-individual-autonomic-domains-in-parkinsons-disease/14235/Are patients with Parkinson’s disease who experience impairment of the autonomic nervous system at greater risk for aggressive disease progression?Iron Sequestration in Microbiota Biofilms in Treatment for IBD
https://reachmd.com/programs/Audioabstracts/iron-sequestration-in-microbiota-biofilms-in-treatment-for-ibd/10712/This integrative study provides deeper understanding of the interactivity between microbiota and anti-inflammatory drugs currently used to treat IBD.Behind-the-Scenes Look into Health Information Exchange
https://reachmd.com/programs/primary-care-today/behind-the-scenes-look-into-health-information-exchange/10493/An astounding electronic evolution is continuing to improve healthcare and the transfer of information. How will data transform your patients’ care?Top Non-Pharmacologic Interventions for Rheumatoid Arthritis
https://reachmd.com/programs/conference-coverage/top-non-pharmacologic-interventions-for-rheumatoid-arthritis/10303/When it comes to improving your rheumatoid arthritis patients’ symptoms, these non-pharmacologic interventions cannot be overlooked.FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
https://reachmd.com/programs/FDA-Drug-Information-Updates/fda-review-adding-labas-ics-treatment-does-not-significantly-increase-serious-asthma-outcomes-risk/9950/The FDA found no significant increase in risk of serious asthma outcomes combining long-acting beta agonists (LABAs) and inhaled corticosteroids (ICS)The Angry Smile: Exploring the Psychological Impacts of Passive-Aggressive Behavior
https://reachmd.com/programs/primary-care-today/angry-smile-exploring-psychological-impacts-passive-aggressive-behavior/9712/Author Signe Whitson offers real-world examples and empowering, practical strategies for individuals confronted with passive aggressiveness.